4,153 articles in this topic
Tregzi, a personalized T cell therapy, wins FDA approval to reduce dangerous immune complications in blood cancer stem cell transplant patients.
A 25-year Lancet study finds adults over 40 with obesity now show cardiovascular markers rivaling normal-weight peers, thanks to medications.
From a 20% lifespan boost in mice to Alzheimer's glycosylation hallmarks, June's research roundup delivers dense longevity science.
A new review reveals how the deadenylase PARN governs telomerase RNA maturation, linking RNA decay to telomere length, aging, and disease.
An AI-engineered antisense oligonucleotide slashes toxic progerin levels, reverses cardiovascular damage, and dramatically extends lifespan in progeria models.
A large multi-omics study confirms sarcopenia and osteoporosis fuel each other — and share genetic, protein, and metabolic pathways.
A targeted RNA therapy reverses hematopoietic decline in aged mice and human stem cells by silencing a key telomere-driven damage pathway.
A newly identified protein in blood vessel walls slows vascular aging in mice — and gene therapy targeting it shows promising results.
A 2025 meta-analysis of 12 RCTs confirms berberine meaningfully improves key metabolic syndrome markers with a favorable safety profile.
New research shows CD38 fuels epithelial ovarian cancer progression via PI3K-AKT and IL-6 pathways, while a CD38 inhibitor curbs tumor growth and immune suppression.
A comprehensive review of parathyroid hormone analogs reveals expanding therapeutic roles in osteoporosis, hypoparathyroidism, and fracture healing.
A major review clarifies how to identify and manage T2-low asthma, a poorly understood subtype lacking standard biomarkers and biologics.
